Michael Brundage, MSc, FRCPC, MD (Interim Director, QCRI) has appointed Christopher Booth, MD, FRCPC as Director… Read More
The global pandemic has significantly disrupted health care around the world, including cancer diagnoses and treatments, leaving many patients waiting for care during an already… Read More
A huge congratulations to our CBG Division's Dr. Andrew Craig on obtaining a 5-year CIHR Project Grant entitled "Targeting TGF-beta signaling to achieve durable therapy responses in preclinical… Read More